Compare Norfolk Southern Corporation (NSC) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Norfolk Southern Corporation trades at $317.79 (market cap $71.20B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Norfolk Southern Corporation is far larger — about 4.2× Zimmer Biomet Holdings Inc's market cap, and Norfolk Southern Corporation pays the higher dividend (1.7%). Which is the better fit depends on your goals — on Pluang, investors hold Norfolk Southern Corporation for 33 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| NSC | ZBH | |
|---|---|---|
Market Cap | $71.20B | $16.95B |
Volume | 555,248 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $352.98 | $103.98 |
52-Week Low | $278.19 | $79.58 |
Typical Hold Time | 33 Days | 89 Days |
Enterprise Value | $86.75B | $24.02B |
Dividend Yield | 1.7% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Norfolk Southern (NSC) trades at $316.99, up 1.21% with bullish technical indicators and strong institutional support. The company demonstrates solid fundamentals with consistent earnings beats, a 21.02% net income margin, and robust cash flow from operations. Recent news highlights momentum for the proposed Union Pacific merger, with regulatory review advancing and over 500 customer endorsements supporting the combination's potential benefits.
NSC presents a favorable risk-reward profile with analyst consensus target of $361.86 offering 14% upside. Key opportunities include freight share gains from trucking and merger synergies, while risks involve fuel price pressures and regulatory hurdles for the combination. The stock remains well-positioned for long-term growth with dividend stability.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
